Premium
A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia
Author(s) -
Tomlinson Benjamin K.,
Tuscano Joseph M.,
Abedi Mehrdad,
Welborn Jeanna,
Arora Mili,
O'Donnell Robert T.,
Wun Ted,
Jonas Brian A.
Publication year - 2019
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.25605
Subject(s) - medicine , myeloid leukemia , bortezomib , oncology , doxorubicin , leukemia , pharmacology , cancer research , chemotherapy , multiple myeloma